In various cancer types, magnolol exerted the inhibitory effect on NF-κB activity, which is demonstrated by studies of breast cancer [15], cholangiocarcinoma [17], colon cancer [23], liver cancer [34,36], lung cancer [39], myeloma [44], ovarian cancer [48] and skin cancer [57] (Table 1 and Figure 2). The gene discussed is NFKB1; the disease is cancer.